Clinical Study to Evaluate the Safety and Anti-Tumor Activity of AB-201

计划入组 18 人 · 首次发布于 2026 年 1 月 12 日

A Study to Evaluate Safety, Tolerability, Dosimetry, and Preliminary Efficacy of the HER2 Directed Radioligand CAM-H2 in Patients With Advanced/Metastatic HER2-Positive Breast, Gastric, and Gastro-Esophageal Junction (GEJ) Cancer

计划入组 13 人 · 首次发布于 2020 年 7 月 13 日

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

计划入组 726 人 · 首次发布于 2024 年 12 月 12 日

Gastric Cancer(EpiVax)

Gastric Cancer Vaccine(WestGene)

Gastric Mucin

CENTER WEST CANCER

United States

Fujian Cancer Hospital (Fujian Cancer Institute, Fujian Cancer Prevention and Treatment Center)

China

Arvinas

United States

Evorpacept Shows Promise in HER2-Positive Gastric Cancer: Phase 2 ASPEN-06 Trial Results

ALX Oncology's Evorpacept Shows Promise in Multiple Cancer Trials

KEYNOTE-811 Trial Shows Pembrolizumab Combination Improves Response Rates in HER2-Positive Gastric Cancer